Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2021

Feb 14, 2022

BUY
$247.59 - $304.47 $3.89 Million - $4.78 Million
15,700 Added 307.84%
20,800 $5.51 Million
Q3 2021

Nov 15, 2021

SELL
$194.77 - $324.21 $1.19 Million - $1.98 Million
-6,100 Reduced 54.46%
5,100 $1.47 Million
Q2 2021

Aug 16, 2021

BUY
$165.87 - $220.95 $1.66 Million - $2.21 Million
10,000 Added 833.33%
11,200 $2.24 Million
Q1 2021

May 17, 2021

SELL
$180.37 - $226.26 $234,481 - $294,138
-1,300 Reduced 52.0%
1,200 $233,000
Q3 2020

Nov 16, 2020

BUY
$122.51 - $158.27 $306,275 - $395,675
2,500 New
2,500 $369,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.91B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.